Skip to main content
See every side of every news story
Published loading...Updated

Ozempic personality is not a side effect — it is the point

A medical conference in Istanbul is hearing the argument that GLP-1 agonists could do for obesity what tobacco litigation did for smoking — move the moral weight off the individual and onto the industry that engineered the demand. In the popular health press, simultaneously, a different argument is taking shape, this one less editorial than testimonial: patients on these drugs are reporting a flattening of pleasure that extends past food, into s…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Martin Cid Magazine broke the news on Thursday, May 14, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal